Skip Navigation


European Heart Journal Advance Access originally published online on June 9, 2008
European Heart Journal 2008 29(15):1922-1923; doi:10.1093/eurheartj/ehn245
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/15/1922-a    most recent
ehn245v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ferrante, G.
Right arrow Articles by Niccoli, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrante, G.
Right arrow Articles by Niccoli, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study

Giuseppe Ferrante

Institute of Cardiology
Catholic University of the Sacred Heart
Largo Agostino Gemelli, 8
00168, Rome
Italy
Tel: +39 06 30154187
Fax: +39 06 3055535
Email: giu.ferrante@hotmail.it
Cardiovascular Department
Royal Brompton Hospital
London
UK

Nicola Cosentino

Institute of Cardiology
Catholic University of the Sacred Heart
Rome
Italy

Peter Barlis

Cardiovascular Department
Royal Brompton Hosptial
London
UK

Giampaolo Niccoli

Institute of Cardiology
Catholic University of the Sacred Heart
Rome
Italy

The first 10% of the full text of this article appears below.

We read with interest the article by Schnabel et al.1 in which the authors assessed the prognostic value of baseline levels of adiponectin in patients with manifest coronary artery disease (CAD). They conclude that adiponectin concentration is predictive of cardiovascular death or non-fatal myocardial infarction (MI) at a median . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?